Houda Hachad

1.8k total citations
25 papers, 1.1k citations indexed

About

Houda Hachad is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Houda Hachad has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 16 papers in Pediatrics, Perinatology and Child Health and 7 papers in Oncology. Recurrent topics in Houda Hachad's work include Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Drug Transport and Resistance Mechanisms (7 papers). Houda Hachad is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Drug Transport and Resistance Mechanisms (7 papers). Houda Hachad collaborates with scholars based in United States, China and Netherlands. Houda Hachad's co-authors include René H. Levy, Isabelle Ragueneau‐Majlessi, Stuart A. Scott, Victoria M. Pratt, Karen E. Weck, Yuan Ji, Michelle Whirl‐Carrillo, Andria L. Del Tredici, Lisa V. Kalman and Ann M. Moyer and has published in prestigious journals such as Neurology, Epilepsia and Clinical Pharmacology & Therapeutics.

In The Last Decade

Houda Hachad

25 papers receiving 1.1k citations

Peers

Houda Hachad
JJ Swen Netherlands
J K Hicks United States
Roseann S. Gammal United States
Johanna Sistonen Finland
Johannes Mulder Netherlands
Sebastian Raimundo Germany
Qun‐Ying Yue Sweden
R PEARCE United States
Stephanie Faucette United States
JS Leeder United States
JJ Swen Netherlands
Houda Hachad
Citations per year, relative to Houda Hachad Houda Hachad (= 1×) peers JJ Swen

Countries citing papers authored by Houda Hachad

Since Specialization
Citations

This map shows the geographic impact of Houda Hachad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houda Hachad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houda Hachad more than expected).

Fields of papers citing papers by Houda Hachad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houda Hachad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houda Hachad. The network helps show where Houda Hachad may publish in the future.

Co-authorship network of co-authors of Houda Hachad

This figure shows the co-authorship network connecting the top 25 collaborators of Houda Hachad. A scholar is included among the top collaborators of Houda Hachad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houda Hachad. Houda Hachad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2024). DPYD Genotyping Recommendations. Journal of Molecular Diagnostics. 26(10). 851–863. 21 indexed citations
2.
Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2023). CYP3A4 and CYP3A5 Genotyping Recommendations. Journal of Molecular Diagnostics. 25(9). 619–629. 33 indexed citations
3.
Turner, Amy, Charity Nofziger, Bronwyn Ramey-Hartung, et al.. (2023). PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting. Clinical Pharmacology & Therapeutics. 114(6). 1220–1237. 16 indexed citations
4.
5.
Pratt, Victoria M., Larisa H. Cavallari, Andria L. Del Tredici, et al.. (2021). Recommendations for Clinical CYP2D6 Genotyping Allele Selection. Journal of Molecular Diagnostics. 23(9). 1047–1064. 97 indexed citations
6.
Pratt, Victoria M., Larisa H. Cavallari, Andria L. Del Tredici, et al.. (2020). Recommendations for Clinical Warfarin Genotyping Allele Selection. Journal of Molecular Diagnostics. 22(7). 847–859. 45 indexed citations
7.
Pratt, Victoria M., Larisa H. Cavallari, Andria L. Del Tredici, et al.. (2019). Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists. Publisher. 12 indexed citations
8.
Pratt, Victoria M., Larisa H. Cavallari, Andria L. Del Tredici, et al.. (2019). Recommendations for Clinical CYP2C9 Genotyping Allele Selection. Journal of Molecular Diagnostics. 21(5). 746–755. 95 indexed citations
9.
Nofziger, Charity, Amy Turner, Katrin Sangkuhl, et al.. (2019). PharmVar GeneFocus: CYP2D6. Clinical Pharmacology & Therapeutics. 107(1). 154–170. 158 indexed citations
10.
Pratt, Victoria M., Andria L. Del Tredici, Houda Hachad, et al.. (2018). Recommendations for Clinical CYP2C19 Genotyping Allele Selection. Journal of Molecular Diagnostics. 20(3). 269–276. 141 indexed citations
11.
Thorn, Caroline F., Michelle Whirl‐Carrillo, Houda Hachad, et al.. (2018). Essential Characteristics of Pharmacogenomics Study Publications. Clinical Pharmacology & Therapeutics. 105(1). 86–91. 10 indexed citations
12.
Birbeck, Gretchen L., Jacqueline A. French, Emilio Perucca, et al.. (2012). Antiepileptic drug selection for people with HIV/AIDS: Evidence‐based guidelines from the ILAE and AAN. Epilepsia. 53(1). 207–214. 39 indexed citations
13.
Birbeck, Gretchen L., Jacqueline A. French, Emilio Perucca, et al.. (2012). Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS. Neurology. 78(2). 139–145. 63 indexed citations
14.
Hachad, Houda, et al.. (2011). e-PKGene: A knowledge-based research tool for analysing the impact of genetics on drug exposure. Human Genomics. 5(5). 506–506. 2 indexed citations
15.
Hachad, Houda, Isabelle Ragueneau‐Majlessi, & René H. Levy. (2010). A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database. Human Genomics. 5(1). 61–61. 55 indexed citations
16.
Yeung, Catherine K., et al.. (2010). Are Circulating Metabolites Important in Drug–Drug Interactions?: Quantitative Analysis of Risk Prediction and Inhibitory Potency. Clinical Pharmacology & Therapeutics. 89(1). 105–113. 57 indexed citations
17.
Ragueneau‐Majlessi, Isabelle, et al.. (2007). Quantitative Correlations Among CYP3A Sensitive Substrates and Inhibitors:Literature Analysis. Current Drug Metabolism. 8(8). 810–814. 14 indexed citations
18.
Lévy, R H, et al.. (2006). Prediction of Maximum Exposure in Poor Metabolizers Following Inhibition of Nonpolymorphic Pathways. Current Drug Metabolism. 7(3). 295–299. 9 indexed citations
19.
Levy, René H., Houda Hachad, Cong-Hui Yao, & Isabelle Ragueneau‐Majlessi. (2003). Relationship Between Extent of Inhibition and Inhibitor Dose: Literature Evaluation Based on the Metabolism and Transport Drug Interaction Database. Current Drug Metabolism. 4(5). 371–380. 11 indexed citations
20.
Hachad, Houda, Isabelle Ragueneau‐Majlessi, & René H. Levy. (2002). New Antiepileptic Drugs: Review on Drug Interactions. Therapeutic Drug Monitoring. 24(1). 91–103. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JJ Swen Breakdown of academic impact, for papers by J K Hicks Breakdown of academic impact, for papers by Roseann S. Gammal Breakdown of academic impact, for papers by Johanna Sistonen Breakdown of academic impact, for papers by Johannes Mulder Breakdown of academic impact, for papers by Sebastian Raimundo Breakdown of academic impact, for papers by Qun‐Ying Yue Breakdown of academic impact, for papers by R PEARCE Breakdown of academic impact, for papers by Stephanie Faucette Breakdown of academic impact, for papers by JS Leeder
Rankless by CCL
2026